Roughly 200 million women around the world suffer from endometriosis, a condition that causes tissue from the lining of the uterus to grow in places outside of the uterus. The condition can be exceptionally painful and contributes to infertility.

Endometriosis is as common as Type 2 diabetes, rheumatoid arthritis and migraines in the U.S., although there is less awareness of this condition. This lack of familiarity with endometriosis among the general population and health care providers means this condition is not well understood.

“Endometriosis is an understudied disease,” said Asgerally Fazleabas, University Distinguished Professor and associate chair of research in the Department of Obstetrics, Gynecology and Reproductive Biology in the Michigan State University College of Human Medicine. “Unless you go to a physician who knows what endometriosis is, it may be misinterpreted as a gastrointestinal problem or inflammatory bowel disease.”

 New findings from a team that includes MSU researchers points the way to developing new non-hormonal therapies which could be a game changer for endometriosis patients, some of whom wait seven to 10 years for a diagnosis. This research was funded by the National Institutes of Health and the Endometriosis Foundation of America.